← All organizations

BiPar Sciences

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Oct 1, 2007

Acquired by Sanofi-Aventis on Apr 15, 2009

Timeline

2000s

Jun 1, 2002
BiPar Sciences— Founded
Apr 15, 2009
Sanofi-Aventis— Acquired By

Drugs by trial phase (3 distinct, 1 trials)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Breast Neoplasms

Recent trials (1)

NCT00540358CollaboratorPhase 2Oct 1, 2007

Details

Founded: Brisbane, CA, US Jun 1, 2002
Last known activity: Oct 1, 2007